Financials
- Market Capitalization 263.98 M
- Employee 152
- Founded 2016
- CEO N/A
- Website www.entradatx.com
- Headquarter Delaware, United States
- FIGI BBG00MTSMC16
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.15
市销率
91.18
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3414 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.06 USD | +5.10% | +0.98% | +23.35% | +14.44% | 271.99 M USD | ||
| 3419 | ALXO ALX Oncology Holdings Inc. - Common Stock | 2.00 USD | +1.52% | -15.25% | +25.79% | +325.53% | 269.13 M USD | ||
| 3440 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.29 USD | -5.19% | -4.08% | -6.53% | -33.94% | 262.03 M USD | ||
| 3459 | SRZN Surrozen, Inc. - Common Stock | 21.88 USD | -4.08% | -4.87% | -5.65% | +162.98% | 254.03 M USD |